<DOC>
	<DOCNO>NCT00209456</DOCNO>
	<brief_summary>The study design determine diagnostic efficacy visual assessment SPECT scan differentiate probable dementia Lewy Bodies ( DLB ) non-DLB dementia subject determine clinical diagnosis independent expert consensus panel use standard truth .</brief_summary>
	<brief_title>Dopamine Transporter Scintigraphy Imaging ( DAT-Imaging ) Patients With Lewy Body Dementia</brief_title>
	<detailed_description>GEHC decide notto provide detail</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia , Vascular</mesh_term>
	<mesh_term>Lewy Body Disease</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<criteria>Subjects must adults 55 90 year age establish diagnosis dementia accordance DSMIV criterion fulfil least one following : The ICC criterion probable possible DLB , National Institute Neurological Communicative Disorders Stroke Alzheimer Disease Related Disorders Association ( NINCDSADRDA ) Alzheimer ’ Disease ( AD ) , National Institute Neurological Communicative Disorders Association Internationale Pour la Recherche et l ’ Enseignement en Neurosciences ( NINCSAIREN ) Vascular Dementia ( VaD ) . Subjects eligible Mini Mental State Examination ( MMSE ) score &lt; 10 use medication know suspect interact striatal uptake DaTSCAN dopamine transporter . Furthermore subject eligible diagnosed idiopathic Parkinson ’ Disease ( PD ) , persistent severe depression , normal pressure hydrocephalus , multiple system atrophy , corticobasal degeneration Huntington ’ Chorea Disease .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Lewy Body Dementia</keyword>
	<keyword>non-DLB dementia</keyword>
	<keyword>Dopamine Transporter</keyword>
	<keyword>Striatal Uptake</keyword>
</DOC>